This paper is in the following e-collection/theme issue:

Pharmacovigilance (138) JMIR Theme Issue: COVID-19 Special Issue (2461) Infectious Diseases (non-STD/STI) (1592) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (159) Pharmacology and Pharmaceutics (70) COVID-19 Vaccination (155) Vaccination and Immunization in the Digital Age (378)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/45263, first published .
Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Authors of this article:

Hung Thai-Van1, 2, 3 Author Orcid Image ;   Marie-Blanche Valnet-Rabier4 Author Orcid Image ;   Maëva Anciaux2 Author Orcid Image ;   Aude Lambert5 Author Orcid Image ;   Anaïs Maurier6 Author Orcid Image ;   Judith Cottin7 Author Orcid Image ;   Tessa Pietri8 Author Orcid Image ;   Alexandre Destère9 Author Orcid Image ;   Marlène Damin-Pernik10 Author Orcid Image ;   Fanny Perrouin11 Author Orcid Image ;   Haleh Bagheri12 Author Orcid Image
Article Authors Cited by (7) Tweetations (868) Metrics

Journals

  1. Reynard P, Thai-Van H. Drug-induced hearing loss: Listening to the latest advances. Therapies 2024;79(2):283 View
  2. Liew X, Tang Z, Ong Y, See K. Hearing Loss after COVID-19 and Non-COVID-19 Vaccination: A Systematic Review. Vaccines 2023;11(12):1834 View
  3. Thai-Van H, Bagheri H, Valnet-Rabier M. Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality Assessment. Vaccines 2024;12(2):181 View
  4. . Elasomeran/tozinameran. Reactions Weekly 2024;2000(1):153 View
  5. Skare T, de Carvalho J, de Medeiros I, Shoenfeld Y. Ear abnormalities in chronic fatigue syndrome (CFS), fibromyalgia (FM), Coronavirus-19 infectious disease (COVID) and long-COVID syndrome (PCS), sick-building syndrome (SBS), post-orthostatic tachycardia syndrome (PoTS), and autoimmune/inflammatory syndrome induced by adjuvants (ASIA): A systematic review. Autoimmunity Reviews 2024;23(10):103606 View
  6. Crommelynck S, Grandvuillemin A, Ferard C, Mounier C, Gault N, Pierron E, Jacquot B, Vaillant T, Chatelet I, Jacquet A, Salvo F, Alt M, Bagheri H, Micallef J, Pariente A, Gautier S, Valnet-Rabier M, Atzenhoffer M, Lepelley M, Cottin J, Lacroix I, Gras V, Massy N, Dhanani A, Vella P, Shaim Y, Baril L, Jonville-Béra A, Benkebil M. The enhanced national pharmacovigilance system implemented for COVID-19 vaccines in France: A 2-year experience report. Therapies 2024 View

Books/Policy Documents

  1. Morgan A, Bosak J, Hagenstein L, Ambler A, Brooks B. . View